| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |